Trial
NCT03848403
Study of Ixekizumab in Healthy Participants
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Healthy
Intervention
Ixekizumab
Why stopped
At the protocol-specified interim analysis, the sponsor decided to stop the trial.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-11-30